Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement.
McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM, Torres AJ, Shahanavaz S, Goldstein BH, Cabalka AK, Bauser-Heaton H, Georgiev S, Berger F, Millan-Iturbe O, Peng LF, Armstrong AK, Levi DS, Fronczak-Jakubczyk A, Sondergaard L, Anderson JH, Schranz D, Jones TK, Cheatham JP, Schubert S, Ewert P.
McElhinney DB, et al.
J Am Coll Cardiol. 2021 Aug 10;78(6):575-589. doi: 10.1016/j.jacc.2021.05.044.
J Am Coll Cardiol. 2021.
PMID: 34353535
Free article.
BACKGROUND: Endocarditis has emerged as one of the most impactful adverse events after transcatheter pulmonary valve replacement (TPVR), but there is limited information about risk factors for and outcomes of this complication. ...
BACKGROUND: Endocarditis has emerged as one of the most impactful adverse events after transcatheter pulmonary valve replac …